Pde3a and Pde3b regulation of murine pulmonary artery smooth muscle cell growth and metabolism
Physiological Reports · 2024
DOI: 10.14814/phy2.70089 ↗At a glance
Journal article in Physiological Reports, 2024. Written by Paulina N Krause and 6 co-authors. Institution: Center for Perinatal Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA. Major MEDLINE topics: Cell Proliferation, Cyclic Nucleotide Phosphodiesterases, Type 3, Myocytes, Smooth Muscle, Pulmonary Artery. Cited 6 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), National Heart, Lung, and Blood Institute.
Abstract (original language)
A role for metabolically active adipose tissue in pulmonary hypertension (PH) pathogenesis is emerging. Alterations in cellular metabolism in metabolic syndrome are triggers of PH‐related vascular dysfunction. Metabolic reprogramming in proliferative pulmonary vascular cells causes a metabolic switch from oxidative phosphorylation to glycolysis. PDE3A and PDE3B subtypes in the regulation of metabolism in pulmonary artery smooth muscle cells (PASMC) are poorly understood. We previously found that PDE3A modulates the cellular energy sensor, AMPK, in human PASMC. We demonstrate that global Pde3a knockout mice have right ventricular (RV) hypertrophy, elevated RV systolic pressures, and metabolic dysfunction with elevated serum free fatty acids (FFA). Therefore, we sought to delineate Pde3a/Pde3b regulation of metabolic pathways in PASMC. We found that PASMC Pde3a deficiency, and to a lesser extent Pde3b deficiency, downregulates AMPK, CREB and PPARγ, and upregulates pyruvate kinase dehydrogenase expression, suggesting decreased oxidative phosphorylation. Interestingly, siRNA Pde3a knockdown in adipocytes led to elevated FFA secretion. Furthermore, PASMC exposed to siPDE3A‐transfected adipocyte media led to decreased α‐SMA, AMPK and CREB phosphorylation, and greater viable cell numbers compared to controls under the same conditions. These data demonstrate that deficiencies of Pde3a and Pde3b alter pathways that affect cell growth and metabolism in PASMC.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Perinatal Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
ORCID profiles: Leif D Nelin, Bernadette Chen
Funding
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- National Heart, Lung, and Blood Institute
Cite
APA
Krause, P. N., McGeorge, G., McPeek, J. L., Khalid, S., Nelin, L. D., Liu, Y., & Chen, B. (2024). Pde3a and Pde3b regulation of murine pulmonary artery smooth muscle cell growth and metabolism. Physiological Reports. https://doi.org/10.14814/phy2.70089
Vancouver
Krause PN, McGeorge G, McPeek JL, Khalid S, Nelin LD, Liu Y, et al. Pde3a and Pde3b regulation of murine pulmonary artery smooth muscle cell growth and metabolism. Physiological Reports. 2024. doi:10.14814/phy2.70089
BibTeX
@article{Krause2024,
author = {Krause, Paulina N and McGeorge, Gabrielle and McPeek, Jennifer L and Khalid, Sidra and Nelin, Leif D and Liu, Yusen and Chen, Bernadette},
title = {Pde3a and Pde3b regulation of murine pulmonary artery smooth muscle cell growth and metabolism},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.70089}
}
EUVIMED